Your browser doesn't support javascript.
loading
An overlook on the current registries for rare and complex connective tissue diseases and the future scenario of TogethERN ReCONNET.
Bandeira, Matilde; Di Cianni, Federica; Marinello, Diana; Arnaud, Laurent; Cannizzo, Sara; Carta, Claudio; Cornet, Alain; Barril, Sara M; Bulina, Inita; Ferraris, Alessandro; Fonseca, João; Gaglioti, Andrea; Limper, Marteen; Lorenzoni, Valentina; Majnik, Judith; Matucci-Cerinic, Marco; Palla, Ilaria; Rednic, Simona; Schneider, Matthias; Smith, Vanessa; Sulli, Alberto; Søndergaard, Klaus; Ticciati, Simone; Tincani, Angela; Turchetti, Giuseppe; Talarico, Rosaria; Cutolo, Maurizio; Mosca, Marta; Taruscio, Domenica.
Afiliação
  • Bandeira M; Rheumatology Department, Lisbon Academic Medical Centre, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
  • Di Cianni F; Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Marinello D; Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy.
  • Arnaud L; Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy.
  • Cannizzo S; Rheumatology Department, Hôpitaux Universitaires de Strasbourg, Centre National de Référence des Maladies Systémiques et Auto-immunes Rares Grand-Est Sud-Ouest, Strasbourg, France.
  • Carta C; Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy.
  • Cornet A; Institute of Management, Sant'Anna School of Advanced Studies, Pisa, Italy.
  • Barril SM; National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Bulina I; Lupus Europe, Brussels, Belgium.
  • Ferraris A; Rheumatology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Fonseca J; Department of Rheumatology, Stradins Clinical University Hospital, Riga, Latvia.
  • Gaglioti A; Medical Genetics Laboratory, Molecular Medicine Department, San Camillo Forlanini Hospital, Sapienza University, Rome, Italy.
  • Limper M; Rheumatology Department, Lisbon Academic Medical Centre, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
  • Lorenzoni V; Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Majnik J; Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy.
  • Matucci-Cerinic M; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Palla I; Institute of Management, Sant'Anna School of Advanced Studies, Pisa, Italy.
  • Rednic S; Department of Rheumatology and Clinical Immunology, Semmelweis University, Budapest, Hungary.
  • Schneider M; Division of Rheumatology and Scleroderma Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria (AOU) Careggi, University of Florence, Florence, Italy.
  • Smith V; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.
  • Sulli A; Department of Rheumatology, Emergency County Teaching Hospital, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.
  • Søndergaard K; Institute of Management, Sant'Anna School of Advanced Studies, Pisa, Italy.
  • Ticciati S; Department of Rheumatology, Emergency County Teaching Hospital, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.
  • Tincani A; Department of Rheumatology, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Turchetti G; Department of Rheumatology, Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium.
  • Talarico R; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Centre, Ghent, Belgium.
  • Cutolo M; Laboratory of Experimental Rheumatology, Division of Clinical Rheumatology, Department of Internal Medicine (DIMI), University of Genoa, Genoa, Italy.
  • Mosca M; IRCCS Polyclinic Hospital San Martino, Genoa, Italy.
  • Taruscio D; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
Front Med (Lausanne) ; 9: 889997, 2022.
Article em En | MEDLINE | ID: mdl-36226147
ABSTRACT

Background:

Patient registries play a crucial role in supporting clinical practice, healthcare planning and medical research, offering a real-world picture on rare and complex connective tissue diseases (rCTDs). ERN ReCONNET launched the first European Registry Infrastructure with the aim to plan, upgrade and link registries for rCTDs, with the final goal to promote a harmonized data collection approach all over Europe for rCTDs.

Methods:

An online survey addressed to healthcare professionals and patients' representatives active in the field of rCTDs was integrated by an extensive database search in order to build a mapping of existing registries for rCTDs.

Findings:

A total of 140 registries were found, 38 of which include multiple diseases. No disease-specific registry was identified for relapsing polychondritis, mixed connective tissue disease and undifferentiated connective tissue disease.

Discussion:

This overview on the existing registries for rCTDs provides a useful starting point to identify the gaps and the strengths of registries on the coverage of rCTDs, and to develop a common data set and data collection approach for the establishment of the TogethERN ReCONNET Infrastructure.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article